Tarbox Family Office’s Calithera Biosciences, Inc CALA Stock Holding History

Tarbox Family Office’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	-$25K	–	107
2022 Q2	$25K	Buy	+10,000	New	+$46.4K	0.01%	104
2021 Q4	–	Sell	-500	Closed	-$22K	–	1205
2021 Q3	$22K	Sell	500 -550	-52%	-$23.7K	﹤0.01%	365
2021 Q2	$44K	Buy	+1,050	New	+$46.1K	0.01%	257

Other funds holding CALA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCMG

TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Tarbox Family Office's CALA Position: Q3 2022 in Review

Tarbox Family Office sold out of Calithera Biosciences, Inc (CALA) in Q3 2022, closing a stake of 10,000 shares — an estimated $25K sold.

Tarbox Family Office first reported a position in CALA in Q2 2021 and held it in 3 quarters. The position peaked at $44K in Q2 2021. 22 funds tracked by Wall St. Rank hold CALA as of Q3 2022.

Tarbox Family Office reported no remaining Calithera Biosciences, Inc position as of Q3 2022 after selling out during the quarter.
Tarbox Family Office sold 10,000 Calithera Biosciences, Inc shares in Q3 2022, an estimated $25K.
Tarbox Family Office first reported a position in Calithera Biosciences, Inc in Q2 2021 and held it in 3 quarters.
Tarbox Family Office's Calithera Biosciences, Inc position peaked at $44K in Q2 2021.
22 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2022.

Based on Tarbox Family Office's 13F filing for Q3 2022, filed 14 Oct 2022.